Global concern over coronavirus vaccine shortages

In this context, Argentina successfully distributed 3,907,765 vaccines and applied 3,134,454 while awaiting the arrival of another batch of Sputnik V vaccine. The administration of Alberto Fernández has succeeded in sourcing vaccines with a high level of efficiency, in significant quantities, and by negotiating bilaterally with the producing countries.

Meanwhile, the extremely high demand resulting from the global pandemic far exceeds the production capacity of individual laboratories around the world, so many have not been able to meet their commitments, according to a report from the chief of staff. cabinet. At the same time, the central countries purchased doses for quantities greater than their population..

In this context, Germany acknowledged this week that the third wave in Europe is inevitable precisely because of the shortage of vaccines. Country like Spain analyzes replication of UK dynamic of vaccinating more people with at least one dose, while other nations, such as Denmark, Hungary or Poland, skip European negotiations to conduct negotiations with China and Russia, in order to acquire their doses.

It didn’t work either, Until now, the COVAX system, which was proposed as a fair, united and rapid alternative to distribute vaccines between countries with fewer resources.

In the region, the Paraguayan government has expressed its dissatisfaction with the provision of COVAX vaccines and in Uruguay cases are increasing and classes are suspended while vaccines are scarce.

As, The Pan American Health Organization (PAHO) has recognized that there is “a bottleneck that prevents us even from providing vaccines to all countries at the same time.”.

For all these reasons, this Sunday BBC He referred to the debate over the release of vaccine patents. “Covid-19 Vaccines: Why Aren’t Patents Published So They Can Be Mass Produced And Reach The World?”, wonders the medium.

In early February, according to the World Health Organization (WHO), some 200 million coronavirus vaccines have been administered: 75% were administered in 10 rich countries.